Clinical Trial Update: Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating docetaxel and liposomal doxorubicin chemotherapy with enoxaparin in advanced pancreatic cancer was terminated; results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Enoxaparin (enoxaparin sodium)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: University of Iowa | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-06-02